Page last updated: 2024-08-24

diminazene aceturate and Reperfusion Injury

diminazene aceturate has been researched along with Reperfusion Injury in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Coutinho, DCO; Cruz, JS; Ferreira, AJ; Foureaux, G; Joviano-Santos, JV; Martins-JĂșnior, PA; Medei, E; Resende, RR; Rodrigues-Ferreira, C; Santos, A; Santos, RAS; Santos-Miranda, A; Vieyra, A1
Han, SJ; Kang, HB; Kim, J; Yoo, K; Yoon, SH1
Gaikwad, AB; Sharma, N1
Li, SM; Liu, F; Wang, XY; Yang, XH1

Reviews

1 review(s) available for diminazene aceturate and Reperfusion Injury

ArticleYear
Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury.
    Peptides, 2022, Volume: 151

    Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Diminazene; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury

2022

Other Studies

3 other study(ies) available for diminazene aceturate and Reperfusion Injury

ArticleYear
Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice.
    Scientific reports, 2022, 10-28, Volume: 12, Issue:1

    Topics: Animals; Apoptosis; Inflammation; Liver; Liver Diseases; Liver Failure; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury

2022
Effects of renal ischemia injury on brain in diabetic and non-diabetic rats: Role of angiotensin II type 2 receptor and angiotensin-converting enzyme 2.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Angiotensin-Converting Enzyme 2; Animals; Brain; Diabetes Mellitus, Experimental; Diminazene; Hyperglycemia; Imidazoles; Kidney Diseases; Kidney Tubules; Male; Malondialdehyde; Nitrites; Rats, Wistar; Receptor, Angiotensin, Type 2; Reperfusion Injury; Sulfonamides; Thiophenes

2020
[ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
    Sheng li xue bao : [Acta physiologica Sinica], 2018, Apr-25, Volume: 70, Issue:2

    Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Hindlimb; Male; Mice; Mice, Inbred ICR; Mice, Transgenic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reperfusion Injury

2018